Figure 1.
Typical lesional areas of epithelioid sarcoma (A), malignant GIST (case 2; B), DFSP (case 7; C), and myofibroblastoma (D). E-H: Immunoreactivity with anti-CD34 antibody exhibited by each of these tumors, respectively.
Typical lesional areas of epithelioid sarcoma (A), malignant GIST (case 2; B), DFSP (case 7; C), and myofibroblastoma (D). E-H: Immunoreactivity with anti-CD34 antibody exhibited by each of these tumors, respectively.